Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study.
Mihaylova B. et al, (2024), Lancet Reg Health Eur, 40
Estimating Costs Associated with Disease Model States Using Generalized Linear Models: A Tutorial.
Zhou J. et al, (2024), Pharmacoeconomics, 42, 261 - 273
Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model.
Wu R. et al, (2024), Br J Gen Pract, 74, e189 - e198
Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States.
Lui JNM. et al, (2023), J Am Heart Assoc, 12
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK.
Zhou J. et al, (2023), Pharmacoeconomics, 41, 547 - 559
Estimating and Extrapolating Survival Using a State-Transition Modeling Approach: A Practical Application in Multiple Myeloma.
Majer I. et al, (2022), Value Health, 25, 595 - 604
Benefit accrual with cardiovascular disease prevention and effects of discontinuation: a modelling study
Wu R. et al, (2022), EUROPEAN HEART JOURNAL, 43, 2850 - 2850
CALIBRATING CARDIOVASCULAR DISEASE POLICY MODEL USING LARGE COHORT DATA
Wu R. et al, (2022), VALUE IN HEALTH, 25, S16 - S16
Cost-effectiveness of statin therapy in categories of patients in the UK
Mihaylova B. et al, (2022), EUROPEAN HEART JOURNAL, 43, 2841 - 2841
EXCESS ANNUAL HOSPITAL COSTS DUE TO CARDIOVASCULAR EVENTS IN A CONTEMPORARY UK POPULATION TO INFORM HEALTH TECHNOLOGY ASSESSMENTS
Zhou J. et al, (2022), VALUE IN HEALTH, 25, S12 - S12
Impact of cardiovascular events on primary and hospital care costs: findings from UK Biobank study
Zhou J. et al, (2022), EUROPEAN HEART JOURNAL, 43, 2852 - 2852
P55 Excess Annual Hospital Costs Due to Cardiovascular Events in a Contemporary UK Population to Inform Health Technology Assessments
Zhou J. et al, (2022), Value in Health, 25, S12 - S12
P70 Calibrating Cardiovascular Disease Policy Model Using Large Cohort Data
Wu R. et al, (2022), Value in Health, 25, S16 - S16
Modelling decay in effectiveness for evaluation of behaviour change interventions: a tutorial for public health economists.
Candio P. et al, (2021), Eur J Health Econ
A model of lifetime health outcomes in cardiovascular disease based on clinical trials and large cohorts
Wu R. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3149 - 3149
Impact of adverse events on quality of life and hospital costs in secondary cardiovascular disease prevention
Lui NMJ. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3159 - 3159
Cost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A Tutorial
Williams C. et al, (2017), Medical Decision Making, 37, 340 - 352
Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic Modeling
Williams C. et al, (2017), Medical Decision Making, 37, 427 - 439
Endovascular Aneurysm Repair: Is Imaging Surveillance Robust, and Does It Influence Long-term Mortality?
Waduud MA. et al, (2015), CardioVascular and Interventional Radiology, 38, 33 - 39
Comorbidity and Intensive Care Outcome — A Multivariable Analysis
Docking R. et al, (2014), Journal of the Intensive Care Society, 15, 205 - 212